GLP-1 drugs and reduction of cancer
Among ~1.6 million people w/ T2 diabetes, for GLP-1 drugs vs insulin Rx, there was less risk for 11 of the 13 cancers associated with obesity
jamanetwork.com/journals/jam...
From the abstract:
“Meaning This study provides clinical data suggesting that GLP-1RAs may reduce the risk of specific OACs compared with insulins.”
This is positive and worrisome at the same time.
Is there something potentially wrong with the insulins being administered?
